Stock Markets March 31, 2026

Citi Opens Coverage on Rheinmetall at Neutral, Flags Risk That Ammunition Demand May Have Peaked

Analyst assigns €1,480 base case target and outlines payoff between sustained peak output and a rapid return to peacetime demand

By Jordan Park
Citi Opens Coverage on Rheinmetall at Neutral, Flags Risk That Ammunition Demand May Have Peaked

Citi Research initiated coverage of Rheinmetall with a neutral rating and a €1,480 target price, arguing that the company’s value hinges on whether current ammunition demand is enduring or temporary. The bank splits valuation between a €330-per-share Weapons and Ammunition component and €1,146 for the rest of the group, while modelling a steep build in sales and earnings through 2028 under its base case. Citi also sets out bull and bear scenarios and lists specific upside risks to its baseline view.

Key Points

  • Citi Research starts coverage with a neutral rating and a €1,480 base case target, viewing the stock as roughly fairly valued at a €1,369 share price.
  • Valuation is split between Weapons and Ammunition (€330 per share using a DCF with 9% WACC) and the rest of the group (€1,146 per share using profit CAGRs to 2031 and 2035).
  • The analysis and outlook materially depend on the ammunition cycle: conflict consumption, post-war stockpile replenishment and peacetime training, with long-run artillery demand modelled near 85,000 rounds per year.

Citi Research opened coverage of German defence manufacturer Rheinmetall on Tuesday with a "neutral" rating and a target price of €1,480 per share. The brokerage said the stock, trading at €1,369 at the time, appears roughly fairly valued under its base case, implying about 8.1% upside in the share price and a 9.1% total expected return when a 1% dividend yield is included.

The analyst framed the core valuation debate succinctly: "peak ammunition or not? Determines whether fair value ~Eur1,500 or Eur1,900-2,100." Citi’s base case falls below both ranges at €1,480.


Valuation framework

Citi divides its valuation into two primary pieces. The Weapons and Ammunition division is valued at €330 per share based on a discounted cash flow using a 9% weighted average cost of capital. That segment’s model assumes the Ukraine conflict ends in 2028, is followed by five to ten years of stockpile rebuilding, and then a sharp reduction to training-only demand at roughly 5-6% of the observed peak production capacity.

The remainder of the business - Vehicle Systems, Digital, Air Defence and Naval - is valued collectively at €1,146 per share. For that block, Citi applies a 28% profit compound annual growth rate (CAGR) to 2031, an 8% CAGR to 2035, and a 3% terminal growth rate thereafter.


Ammunition cycle assumptions

Citi lays out a three-stage sequence it sees governing ammunition demand: active conflict consumption, a post-war phase of stockpile replenishment, and a peacetime training phase. The brokerage highlights a significant ramp-up in European 155mm production capacity as part of the backdrop: roughly 300,000 rounds annually before February 2022, about 2 million currently, and an anticipated further ramp to roughly 3 million over the next three to five years.

On observed usage rates, Citi estimates Russia fired roughly 8.4 million artillery rounds per year between August 2023 and April 2025, an average of about 23,000 rounds per day. The research note also references current RUSI estimates that place Russian daily consumption at 10,000-17,000 rounds per day, a decline that Citi attributes in part to the increased use of FPV attack drones.

Under Citi’s long-run modelling, once stockpiles have been rebuilt, long-run artillery demand for Rheinmetall is modelled at approximately 85,000 rounds per year, around 5-6% of peak capacity.


Financial projections

Citi’s group-level forecasts show sales rising from €9.94 billion in 2025 to €14.31 billion in 2026E, €18.10 billion in 2027E and €22.94 billion in 2028E. Adjusted EBIT is modelled at €2.63 billion in 2026E, €3.44 billion in 2027E and €4.59 billion in 2028E.

Core earnings per share are projected at €39.96 in 2026E, €51.67 in 2027E and €68.32 in 2028E. The implied price-to-earnings multiple is 34.3x on 2026E EPS, declining to 20x by 2028E. Free cash flow to shareholders is estimated at €2.46 billion in 2026E and €2.87 billion in 2028E.


Scenario analysis

Citi presents a bull and bear range around its base case. The bull case values Rheinmetall at €1,910 per share and assumes the Weapons and Ammunition business runs at peak capacity in perpetuity with 100% cash conversion. The bear case comes in at €1,135 per share and assumes only one year for stockpile rebuild, 80% cash conversion and a 3% profit CAGR from 2031-2036.

The firm also identifies four upside risks to its central thesis: ammunition product lines other than 155mm could behave differently than modelled; the Naval division could achieve revenues of €5 billion by 2030 versus Citi’s €2.5 billion projection, in which case Citi estimates this would add about €115 per share; materially stronger near-term free cash flow could arrive from customer advances; and the market could continue to price Rheinmetall on an assumption of uninterrupted growth through 2030.

Rheinmetall is listed on the Frankfurt exchange under RHMG.DE and had a market capitalisation of €63,737 million in Citi’s note.

Risks

  • The possibility that peak ammunition demand is transitory, leading to a return to much lower peacetime training demand that would weigh on Weapons & Ammunition revenues - impacting the defence manufacturing sector.
  • European production capacity expansion for 155mm rounds and uncertainty in sustained demand levels, which could pressure industry margins and utilisation - impacting defence suppliers and industrial manufacturers.
  • Execution or revenue shortfalls in non-ammunition divisions, such as the Naval business failing to reach materially higher revenue trajectories, which would affect the company’s overall valuation and the broader defence equipment sector.

More from Stock Markets

BRCK Group Rejects 65p Approach from Atlas, Shares Spike After Board Deems Offer Too Low Mar 31, 2026 Jakarta Stocks Retreat as Infrastructure, Financials and Agriculture Weigh on Market Mar 31, 2026 UBS Moves Beiersdorf to Neutral as Shares Languish; Low Upside to New €80 Target Mar 31, 2026 Brookfield Purchases Blackstone’s Fidere Residential Portfolio for €1.2 Billion Mar 31, 2026 Unilever in Advanced Talks to Combine Packaged Foods Unit with McCormick as Restructuring Accelerates Mar 31, 2026